A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 39/40 (2006.01) A61K 39/42 (2006.01) C07K 16/24 (2006.01)
Patent
CA 2355896
The invention is based on the isolation of antibodies that were made to a polypeptide having the amino acid sequence for a truncated VEGF-D. One of these antibodies can interfere with the activity of VEGF-D mediated by VEGFR-2 and interfere with the binding of VEGF-D to VEGFR-3 but does not interfere with the activity of VEGF mediated by VEGFR-2 or bind to VEGF-C. The invention provides pharmaceutical and diagnostic compositions and methods utilizing these antibodies.
L'invention concerne l'isolement d'anticorps produits contre un polypeptide présentant la séquence d'acides aminés d'un facteur de croissance endothéliale vasculaire-D (VEGF-D) tronqué. Un de ces anticorps peut perturber l'activité du VEGF-D provoquée par le récepteur du facteur de croissance endothéliale vasculaire-2 (VEGFR-2) et perturber la liaison du VEGF-D au VEGFR-3, mais ne perturbe pas l'activité du VEGF provoqué par le VEGFR-2 ou lié au VEGF-C. L'invention concerne également des compositions à usage pharmaceutique et diagnostique ainsi que des méthodes d'utilisation de ces anticorps.
Achen Marc G.
Stacker Steven Alan
Ludwig Institute For Cancer Research
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Antibodies to truncated vegf-d and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to truncated vegf-d and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to truncated vegf-d and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1748874